NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 118 filers reported holding NUVALENT INC in Q3 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $350,273,609 | +9.0% | 7,619,613 | +0.0% | 0.03% | +11.1% |
Q2 2023 | $321,256,289 | -19.9% | 7,618,124 | -50.5% | 0.03% | +50.0% |
Q1 2023 | $401,286,324 | +76.8% | 15,380,848 | +101.9% | 0.02% | -21.7% |
Q4 2022 | $226,910,497 | +81.1% | 7,619,560 | +18.2% | 0.02% | +76.9% |
Q3 2022 | $125,323,000 | +43.7% | 6,446,671 | +0.2% | 0.01% | +44.4% |
Q2 2022 | $87,215,000 | -2.4% | 6,431,812 | -0.0% | 0.01% | +28.6% |
Q1 2022 | $89,346,000 | -25.7% | 6,432,387 | +0.1% | 0.01% | -22.2% |
Q4 2021 | $120,240,000 | -14.0% | 6,427,307 | 0.0% | 0.01% | -18.2% |
Q3 2021 | $139,875,000 | – | 6,427,307 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $368,253,000 | 7.72% |
Fairmount Funds Management LLC | 914,614 | $17,414,000 | 5.74% |
Bain Capital Life Sciences Investors, LLC | 3,428,014 | $65,269,000 | 5.18% |
VR Adviser, LLC | 803,951 | $15,307,000 | 2.09% |
Boxer Capital, LLC | 1,210,192 | $23,042,000 | 0.90% |
Avoro Capital Advisors LLC | 1,102,671 | $18,431,000 | 0.31% |
BVF INC/IL | 448,512 | $8,540,000 | 0.31% |
Logos Global Management LP | 134,650 | $2,563,000 | 0.26% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,180,696 | $22,480,000 | 0.23% |
Perceptive Advisors | 1,500,000 | $28,560,000 | 0.22% |